A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
about
Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromesDe novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.
P2860
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@ast
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@en
type
label
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@ast
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@en
prefLabel
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@ast
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@en
P2093
P2860
P356
P1433
P1476
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer
@en
P2093
Alberto Maria Martelli
Cecilia Evangelisti
Claudia Ligorio
Giuseppe Gasparre
Laura Benedetta Amato
Laura Maria Pradella
Roberta Zuntini
Simona Ferrari
P2860
P2888
P356
10.1186/1471-2407-14-70
P407
P577
2014-02-06T00:00:00Z
P5875
P6179
1048938606